[16] While some participants in clinical studies have reported menstrual changes, these are generally attributed to the metabolic effects of weight loss rather than direct drug action on reproductive tissues, and are not classified as common adverse effects in the UK product information for GLP-1 medications
Fang L, Li J, Zeng H, Liu J
This approach is particularly useful when various parties file lawsuits concerning shared issues, like the health concerns associated with Ozempic and other drugs
No signal of increased statin-related adverse events (myopathy, rhabdomyolysis, hepatotoxicity) emerged in the semaglutide arm compared with placebo
History of Thyroid Cancer or MEN 2: If you or a family member has had medullary thyroid carcinoma (a rare thyroid cancer) or multiple endocrine neoplasia syndrome type 2 (MEN 2), Ozempic is not recommended